The Time for Breakthroughs in Antibiotic Discovery
Since a revolutionary discovery of penicillin in 1928 by Scottish bacteriologist and Nobel laureate Alexander Fleming, numerous inventions of new …
Novel Therapeutics
The science and business of the emerging therapeutic modalities and therapies.
Three Insights For Immuno-oncology Drug Discovery
Immunotherapies are hot property. Immuno-oncology is the crown jewel. But the road to riches, and more importantly cancer cures, is …
The Explosion of Therapeutic Modalities: Small Molecules, Biologics, and Everything in Between
Since the early days of the pharmaceutical industry, small molecules have been the most extensively used group of drugs. Nowadays, …
A Running List Of Covid-19 Treatments In Development
Disclaimer: This post is not medical advice, it is only for informational purposes. In case of need, consult your doctor …
Protein Degraders Take Industry By Storm
Proteins are essential components of living matter — they function as building blocks for cells and tissues, as well as …
Can The Mucosal Immunity Protect Against COVID-19?
Common vaccines are synonymous with injections and grant you systemic immunity. But the injection isn’t the only way to develop …
Evaxion Biotech Uses AI To Develop Anticancer And Antimicrobial Vaccines
This is an interview with Niels Iversen Møller, a CEO, and Co-founder of Evaxion Biotech -- an immuno-informatics biotech from …
How CRISPR Transforms Modern Drug Discovery
Consensus seems universal and the news about it flows literally by the minute over gene editing as a future therapy, …
Learning From Nature: New Antibiotics Found In Our Body
To date, nature has been the best teacher for drug discovery scientists, especially for those who develop antimicrobial drugs. Lately, …
AI Helps Discover Potential First-in-class Molecule for Immuno-oncology for Fosun Pharma
The global artificial intelligence (AI) leader Insilico Medicine announced its first milestone in cancer immunotherapy for their external collaboration with …
AI Hunt for ALS Treatment Continues With 28 Novel Targets Revealed by Insilico Medicine
Insilico Medicine identified 28 new targets for the treatment of amyotrophic lateral sclerosis (ALS) using its proprietary AI-driven platform PandaOmics. …
The Promise Of Cell Technologies In Immunotherapy
The number of immunotherapies in clinical trial rolls over 5000 now, and immunology has become a common approach in some …
